Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge

  • The PLOS ONE Staff

The last sentence of the “WNV DNA Vaccine, Control Plasmid and E-protein” section of the Materials and Methods should read: “For protein booster vaccine formulation the E-protein was adjuvanted with 10 μg Matrix-M1 adjuvant (Novavax AB, Uppsala, Sweden).”

In addition, the following sentence should be inserted as the last sentence of the “Vaccination Procedures” section of the Materials and Methods: “Mice were boosted four weeks later either via an IM injection of the same does of WNV-DermaVir nanoparticles or via subcutaneous (s.c.) injection of recombinant E-protein ([28]) formulated with Matrix-M1 (a kind gift from Novavax AB, Uppsala, Sweden).”

Reference

  1. 1. De Filette M, Soehle S, Ulbert S, Richner J, Diamond MS, et al. (2014) Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge. PLoS ONE 9(2): e87837

Citation: The PLOS ONE Staff (2014) Correction: Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge. PLoS ONE 9(2): e91631. https://doi.org/10.1371/journal.pone.0091631

Published: February 28, 2014

Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.